16 results on '"Dreyfus J"'
Search Results
2. Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcifications
- Author
-
Dreyfus, J., primary, Cimadevilla, C., additional, Brochet, E., additional, Himbert, D., additional, Iung, B., additional, Vahanian, A., additional, and Messika-Zeitoun, D., additional
- Published
- 2013
- Full Text
- View/download PDF
3. Real-time 3D transoesophageal echocardiography evaluation of the mitral valve area in patients with mitral stenosis
- Author
-
Dreyfus, J., primary, Brochet, E., additional, Lepage, L., additional, Attias, D., additional, Cueff, C., additional, Detaint, D., additional, Iung, B., additional, Vahanian, A., additional, and Messika-Zeitoun, D., additional
- Published
- 2011
- Full Text
- View/download PDF
4. Determinants of symptoms in aortic stenosis – Influence of longitudinal strain
- Author
-
Attias, D., primary, Macron, L., additional, Dreyfus, J., additional, Monin, J.-L., additional, Brochet, E., additional, Lepage, L., additional, Iung, B., additional, Vahanian, A., additional, and Messika-Zeitoun, D., additional
- Published
- 2011
- Full Text
- View/download PDF
5. Unmet needs and knowledge gaps in aortic stenosis: A position paper from the Heart Valve Council of the French Society of Cardiology.
- Author
-
Fauvel C, Coisne A, Capoulade R, Bourg C, Diakov C, Ribeyrolles S, Jouan J, Folliguet T, Kibler M, Dreyfus J, Magne J, Bohbot Y, Pezel T, Modine T, and Donal E
- Subjects
- Humans, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation adverse effects, Consensus, Severity of Illness Index, Treatment Outcome, Cardiology standards, Professional Practice Gaps, Risk Factors, Clinical Decision-Making, Hemodynamics, Predictive Value of Tests, Needs Assessment, Aortic Valve Stenosis physiopathology, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis therapy, Aortic Valve Stenosis diagnosis, Aortic Valve physiopathology, Aortic Valve diagnostic imaging, Aortic Valve surgery
- Abstract
Nowadays, valvular heart disease remains a significant challenge among cardiovascular diseases, affecting millions of people worldwide and exerting substantial pressure on healthcare systems. Within the spectrum of valvular heart disease, aortic stenosis is the most common valvular lesion in developed countries. Despite notable advances in understanding its pathophysiological processes, improved cardiovascular imaging techniques and expanding therapeutic options in recent years, there are still unmet needs and knowledge gaps regarding aortic stenosis pathophysiology, severity assessment, management and decision-making strategy. This review, prepared on behalf of the Heart Valve Council of the French Society of Cardiology, describes these gaps and future research perspectives to improve the outcome of patients with aortic stenosis., (Copyright © 2024. Published by Elsevier Masson SAS.)
- Published
- 2024
- Full Text
- View/download PDF
6. Aortic valve replacement for aortic stenosis: Influence of centre volume on TAVR adoption rates and outcomes in France.
- Author
-
Willner N, Nguyen V, Prosperi-Porta G, Eltchaninoff H, Burwash IG, Michel M, Durand E, Gilard M, Dindorf C, Dreyfus J, Iung B, Cribier A, Vahanian A, Chevreul K, and Messika-Zeitoun D
- Subjects
- Humans, France epidemiology, Female, Male, Aged, Treatment Outcome, Time Factors, Risk Factors, Aged, 80 and over, Practice Patterns, Physicians' trends, Risk Assessment, Retrospective Studies, Postoperative Complications epidemiology, Postoperative Complications mortality, Diffusion of Innovation, Aortic Valve Stenosis surgery, Aortic Valve Stenosis mortality, Aortic Valve Stenosis physiopathology, Aortic Valve Stenosis diagnostic imaging, Hospitals, High-Volume trends, Transcatheter Aortic Valve Replacement trends, Transcatheter Aortic Valve Replacement mortality, Transcatheter Aortic Valve Replacement adverse effects, Hospitals, Low-Volume trends, Aortic Valve surgery, Aortic Valve physiopathology, Databases, Factual, Heart Valve Prosthesis Implantation mortality, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation trends, Heart Valve Prosthesis Implantation instrumentation
- Abstract
Background: Transcatheter (TAVR) has supplanted surgical (SAVR) aortic valve replacement (AVR)., Aim: To evaluate whether adoption of this technology has varied according to centre volume at the nationwide level., Methods: From an administrative hospital-discharge database, we collected data on all AVRs performed in France between 2007 and 2019. Centres were divided into terciles based on the annual number of SAVRs performed in 2007-2009 ("before TAVR era")., Results: A total of 192,773 AVRs (134,662 SAVRs and 58,111 TAVRs) were performed in 47 centres. The annual number of AVRs and TAVRs increased significantly and linearly in low-volume (<152 SAVRs/year; median 106, interquartile range [IQR] 75-129), middle-volume (152-219 SAVRs/year; median 197, IQR 172-212) and high-volume (>219 SAVRs/year; median 303, IQR 268-513) terciles, but to a greater degree in the latter (+14, +16 and +24 AVRs/centre/year and +16, +19 and +31 TAVRs/centre/year, respectively; P
ANCOVA <0.001). Charlson Comorbidity Index and in-hospital death rates declined from 2010 to 2019 in all terciles (all Ptrend <0.05). In 2017-2019, after adjusting for age, sex and Charlson Comorbidity Index, there was a trend toward lower death rates in the high-volume tercile (P=0.06) for SAVR, whereas death rates were similar for TAVR irrespective of tercile (P=0.27). Similar results were obtained when terciles were defined based on number of interventions performed in the last instead of the first 3years. Importantly, even centres in the lowest-volume tercile performed a relatively high number of interventions (150 TAVRs/year/centre)., Conclusions: In a centralized public healthcare system, the total number of AVRs increased linearly between 2007 and 2019, mostly due to an increase in TAVR, irrespective of centre volume. Progressive declines in patient risk profiles and death rates were observed in all terciles; in 2017-2019 death rates were similar in all terciles, although lower in high-volume centres for SAVR., (Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
7. Impact of the coronavirus disease 2019 pandemic on aortic valve replacement and outcomes in France.
- Author
-
Prosperi-Porta G, Nguyen V, Eltchaninoff H, Dreyfus J, Burwash IG, Willner N, Michel M, Durand E, Gilard M, Dindorf C, Iung B, Cribier A, Vahanian A, Chevreul K, and Messika-Zeitoun D
- Subjects
- Female, Humans, Aortic Valve diagnostic imaging, Aortic Valve surgery, Pandemics, Risk Factors, Treatment Outcome, Postoperative Complications, Communicable Disease Control, Hospital Mortality, France epidemiology, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation adverse effects, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis surgery, COVID-19 epidemiology
- Abstract
Background: The coronavirus disease of 2019 (COVID-19) pandemic lockdowns limited access to medical care. The impact on surgical (SAVR) and transcatheter (TAVR) aortic valve replacement (AVR) has been poorly described., Aim: We sought to evaluate the impact of the COVID-19 pandemic on the number and modalities of AVR, patient demographics and in-hospital outcomes at the nationwide level., Methods: Using the French nationwide administrative hospital discharge database, we compared projected numbers and proportions of AVR and hospital outcomes, obtained using linear regressions derived from 2015-2019 trends, with those observed in 2020., Results: In 2020, 21,382 AVRs were performed (13,051 TAVRs, 5706 isolated SAVRs and 2625 SAVRs combined with other cardiac surgery). Compared with the 2020 projected number of AVRs (24,586, 95% confidence interval [CI] 23,525-25,646), TAVRs (14,866, 95% CI 14,164-15,568), isolated SAVRs (6652, 95% CI 6203-7100) and SAVRs combined with other cardiac surgery (3069, 95% CI 2822-3315), there were reductions of 13.0%, 12.2%, 14.2% and 14.5%, respectively. These trends were similar regardless of sex or age. In 2020, the mean age, Charlson Comorbidity Index and hospital admission duration continued to decline, and the proportion of females remained constant, following 2015-2019 trends. Overall, 2020 in-hospital mortality was higher than projected (2.0% observed vs. 1.7% projected; 95% CI 1.5-1.9%), with no increased pacemaker implantation, but more acute kidney injury and cerebrovascular accidents in some surgical subsets., Conclusions: During the COVID-19 pandemic, fewer TAVR and SAVR procedures were performed, with increased in-hospital mortality and periprocedural complications. Extended follow-up will be important to establish the long-term effect of the COVID-19 pandemic on patient management and outcomes., (Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Tricuspid regurgitation: Light at the end of the tunnel?
- Author
-
Dreyfus J, Obadia JF, and Messika-Zeitoun D
- Subjects
- Cardiac Catheterization, Humans, Treatment Outcome, Tricuspid Valve diagnostic imaging, Tricuspid Valve surgery, Heart Valve Prosthesis Implantation, Tricuspid Valve Insufficiency diagnostic imaging, Tricuspid Valve Insufficiency etiology, Tricuspid Valve Insufficiency surgery
- Published
- 2022
- Full Text
- View/download PDF
9. Cardiac remodelling in secondary tricuspid regurgitation: Should we look beyond the tricuspid annulus diameter?
- Author
-
Guérin A, Vabret E, Dreyfus J, Lavie-Badie Y, Sportouch C, Eicher JC, Maréchaux S, Le Tourneau T, and Donal E
- Subjects
- Aged, Aged, 80 and over, Atrial Function, Right, Echocardiography, Doppler, Color, Echocardiography, Doppler, Pulsed, Female, France, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Registries, Severity of Illness Index, Tricuspid Valve diagnostic imaging, Tricuspid Valve Insufficiency diagnostic imaging, Atrial Remodeling, Hemodynamics, Tricuspid Valve physiopathology, Tricuspid Valve Insufficiency physiopathology, Ventricular Function, Right, Ventricular Remodeling
- Abstract
Background: A better understanding of the mechanism of tricuspid regurgitation severity would help to improve the management of this disease., Aim: We sought to characterize the determinants of isolated secondary tricuspid regurgitation severity in patients with preserved left ventricular ejection fraction., Methods: This was a prospective observational multicentre study. Patients with severe tricuspid regurgitation were asked to participate in a registry that required a control echocardiogram after optimization of medical treatment and a follow-up. Patients had to have at least mild secondary tricuspid regurgitation when clinically stable, and were classified according to five grades of tricuspid regurgitation severity, based on effective regurgitant orifice area., Results: One hundred patients with tricuspid regurgitation (12 mild, 31 moderate, 18 severe, 17 massive and 22 torrential) were enrolled. Right atrial indexed volume and tethering area were statistically associated with the degree of tricuspid regurgitation (P<0.001 and P=0.005, respectively). When the tricuspid annular diameter was≥50mm, the probability of having severe tricuspid regurgitation or a higher grade was>70%. For an increase of 10mL/m
2 in right atrial volume, the effective regurgitant orifice area increased by 4.2mm2 , and for an increase of 0.1cm2 in the tethering area, the effective regurgitant orifice area increased by 2.35mm2 . The degree of right ventricular dilation and changes in tricuspid morphology were significantly related to tricuspid regurgitation severity class (P<0.001). No significant difference in right ventricular function variables was observed between the tricuspid regurgitation classes., Conclusions: For tricuspid regurgitation to be severe or torrential, both right atrial dilatation and leaflet tethering are needed. Interestingly, right cavities dilated progressively with tricuspid regurgitation severity, without joint degradation of right ventricular systolic function variables., (Copyright © 2021 Elsevier Masson SAS. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
10. Reproducibility of reading echocardiographic parameters to assess severity of mitral regurgitation. Insights from a French multicentre study.
- Author
-
Coisne A, Aghezzaf S, Edmé JL, Bernard A, Ma I, Bohbot Y, Di Lena C, Nicol M, Lavie Badie Y, Eyharts D, Seemann A, Falaise C, Ternacle J, Nguyen A, Montier G, Hubert A, Montaigne D, Donal E, and Dreyfus J
- Subjects
- Aged, Aged, 80 and over, Female, France, Humans, Male, Middle Aged, Mitral Valve physiopathology, Mitral Valve Insufficiency physiopathology, Observer Variation, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, Echocardiography, Doppler, Color, Mitral Valve diagnostic imaging, Mitral Valve Insufficiency diagnostic imaging
- Abstract
Background: Poor reproducibility in assessment of mitral regurgitation (MR) has been reported., Aim: To investigate the robustness of echocardiographic MR assessment in 2019, based on improvements in technology and the skill of echocardiographists regarding MR quantification., Methods: Reproducibility in parameters of MR severity and global rating were tested using transthoracic echocardiography in 25 consecutive patients independently analysed by 16 junior and senior cardiologists specialized in echocardiography (400 analyses per parameter)., Results: Overall interobserver agreement for mechanism definition, effective regurgitant orifice area (EROA) and regurgitant volume (RVol) was moderate, and was lower in secondary MR. Interobserver agreement was substantial for EROA [0.61, 95% confidence interval (CI) 0.45-0.75] and moderate for RVol with the PISA method (0.50, 95% CI 0.33-0.56) in senior physicians and was fair in junior physicians (0.33, 95% CI 0.19-0.51 and 0.36, 95% CI 0.36-0.43, respectively). Using a multiparametric approach, overall interobserver agreement for grading MR severity was fair (0.30), was slightly better in senior than in junior physicians (0.31 vs. 0.28, respectively) with substantial or almost perfect agreement more frequently observed in senior versus junior physicians (52% vs. 36%, respectively)., Conclusion: Reproducible transthoracic echocardiography MR quantification remains challenging in 2019, despite the expected high skills of echocardiographers regarding MR at the time of dedicated percutaneous intervention. The multiparametric approach does not entirely alleviate the substantial dispersion in measurement of MR severity parameters, whereas reader experience seems to partially address the issue. Our study emphasizes the continuing need for multimodality imaging and education in the evaluation of MR among cardiologists., (Copyright © 2020 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
11. Secondary tricuspid regurgitation: Do we understand what we would like to treat?
- Author
-
Guérin A, Dreyfus J, Le Tourneau T, Sportouch C, Lairez O, Eicher JC, Flécher E, Réant P, and Donal E
- Subjects
- Humans, Magnetic Resonance Imaging, Predictive Value of Tests, Prognosis, Risk Factors, Severity of Illness Index, Tricuspid Valve physiopathology, Tricuspid Valve surgery, Tricuspid Valve Insufficiency etiology, Tricuspid Valve Insufficiency physiopathology, Tricuspid Valve Insufficiency surgery, Echocardiography methods, Hemodynamics, Tricuspid Valve diagnostic imaging, Tricuspid Valve Insufficiency diagnostic imaging
- Abstract
Tricuspid regurgitation has long been a neglected and underestimated entity; its prevalence is significant, and is increasing with the ageing population. Tricuspid regurgitation is often a consequence of chronic left cardiac pathologies or atrial fibrillation. Surgical treatment is recommended for patients with severe symptomatic tricuspid regurgitation or tricuspid annulus dilatation at the time of left heart valve surgery. Secondary tricuspid regurgitation is a complex disease; this review focuses on the need for better understanding of its mechanisms and quantification - mandatory with the advent of new percutaneous treatments., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
12. Correlates of the ratio of acceleration time to ejection time in patients with aortic stenosis: An echocardiographic and computed tomography study.
- Author
-
Altes A, Sochala M, Attias D, Dreyfus J, Bohbot Y, Toledano M, Macron L, Renard C, Chadha G, Truffier A, Guerbaai RA, Ennezat PV, Graux P, Tribouilloy C, and Maréchaux S
- Subjects
- Acceleration, Aged, Aged, 80 and over, Aortic Valve physiopathology, Aortic Valve Stenosis physiopathology, Calcinosis physiopathology, Female, France, Humans, Male, Predictive Value of Tests, Prognosis, Registries, Retrospective Studies, Severity of Illness Index, Time Factors, Aortic Valve diagnostic imaging, Aortic Valve pathology, Aortic Valve Stenosis diagnostic imaging, Calcinosis diagnostic imaging, Echocardiography, Doppler, Stroke Volume, Tomography, X-Ray Computed, Ventricular Function, Left
- Abstract
Background: An increased acceleration time to ejection time (AT/ET) ratio is associated with increased mortality in patients with aortic stenosis (AS)., Aim: To identify the factors associated with an increased AT/ET ratio., Methods: The relationships between the AT/ET ratio and clinical and Doppler echocardiographic variables of interest in the setting of AS were analysed retrospectively in 1107 patients with AS and preserved left ventricular (LV) ejection fraction (LVEF). The computed tomography aortic valve calcium (CT-AVC) score was studied in a subgroup of 342 patients., Results: In the univariate analysis, the AT/ET ratio was found to correlate with peak aortic jet velocity (r=0.57; P<0.0001), mean pressure gradient (r=0.60; P<0.0001), aortic valve area (r=-0.50; P<0.0001) and CT-AVC score (r=0.24; P<0.0001). The AT/ET ratio had good accuracy in predicting a peak aortic jet velocity≥4 m/s, a mean pressure gradient≥40mmHg and an aortic valve area≤1.0cm
2 , with an optimal cut-off value of 0.34. Multivariable linear regression analysis showed that presence of AS-related symptoms, decreased LV stroke volume index, LVEF, absence of diabetes mellitus, systolic blood pressure, increased LV mass index, relative wall thickness and peak aortic jet velocity were independently associated with an increased AT/ET ratio (all P<0.05). In the subgroup of patients who underwent CT-AVC scoring, the CT-AVC score was independently associated with an increased AT/ET ratio (P<0.05)., Conclusions: The AT/ET ratio is related to echocardiographic and CT-AVC indices of AS severity. However, multiple intricate factors beyond the haemodynamic and anatomical severity of AS influence the AT/ET ratio, including LV geometry, function and systolic blood pressure. These findings should be considered when assessing the AT/ET ratio in patients with AS and preserved LVEF., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
13. Transoesophageal echocardiography current practice in France: A multicentre study.
- Author
-
Coisne A, Dreyfus J, Bohbot Y, Pelletier V, Collette E, Cescau A, Cariou E, Alexandrino C, Coulibaly S, Seemann A, Karsenty C, Theron A, Caspar T, Soulat-Dufour L, and Ternacle J
- Subjects
- Aged, Aged, 80 and over, Clinical Competence, Echocardiography, Transesophageal adverse effects, Echocardiography, Transesophageal standards, Female, France, Guideline Adherence trends, Humans, Learning Curve, Male, Middle Aged, Patient Satisfaction, Practice Guidelines as Topic, Practice Patterns, Physicians' standards, Predictive Value of Tests, Prospective Studies, Echocardiography, Transesophageal trends, Heart Diseases diagnostic imaging, Practice Patterns, Physicians' trends
- Abstract
Background: Few data are available on the application of transoesophageal echocardiography (TOE) recommendations in daily practice., Aims: To evaluate TOE practice based on echocardiography societies' guidelines, and to determine complication rates and factors associated with patient feelings., Methods: Between April and June 2017, we prospectively included all consecutive patients referred to 14 French hospitals for a transoesophageal echocardiogram (TOE). A survey was taken just after the examination, which included questions about pre-procedural anxiety, and any pain, unpleasant feeling or breathing difficulties experienced during the examination., Results: Overall, 1718 TOEs were performed, mainly for stroke evaluation. A standardized operating procedure checklist was completed in half of the patients before the examination. TOE was unpleasant for 62.4% of patients, but was stopped for agitation or intolerance in 3.5 and 1.4% of cases, respectively. We observed one severe complication (pulmonary oedema). The mean TOE duration was short (9.2±4.6minutes), but was longer with residents than with more experienced physicians (11±4.7 vs. 8.8±4.7minutes for junior physicians [P=0.0027]; vs. 8.9±4.8minutes for senior physicians [P=0.0013]; and vs. 7.5±4.1minutes for associate professors/professors [P<0.0001]). The visual analogue scale (VAS) score after TOE was good (8.3±1.7 out of 10), and was better in patients with general anaesthesia (GA) than in those without GA (9.3±0.9 vs. 8.1±1.7; P<0.0001). In patients without GA, the VAS score was similar with and without local anaesthesia (8.1±1.7 vs. 8.2±1.6; P=0.19). After multivariable adjustment, absence of anxiety before TOE and greater operator experience were consistently associated with a higher VAS score., Conclusions: TOE is safe, with a low rate of complications and few stops for intolerance. A shorter TOE duration and better patient feelings were observed for experienced operators, highlighting the importance of the learning curve, and paving the way for teaching on a TOE simulator., (Copyright © 2018. Published by Elsevier Masson SAS.)
- Published
- 2018
- Full Text
- View/download PDF
14. Echocardiographic measurement of left atrial volume: Does the method matter?
- Author
-
Cimadevilla C, Nadia B, Dreyfus J, Perez F, Cueff C, Malanca M, Brochet E, Iung B, Vahanian A, and Messika-Zeitoun D
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Healthy Volunteers, Humans, Male, Middle Aged, Prospective Studies, ROC Curve, Young Adult, Atrial Function, Right physiology, Cardiac Volume physiology, Echocardiography methods, Heart Atria diagnostic imaging
- Abstract
Background: Four two-dimensional echocardiographic methods (cube, ellipsoid, Simpson's and area-length) can be used to assess left atrial volume (LAV)., Aims: To compare absolute LAV measurements and evaluate agreement regarding the semiquantitative assessment of degree of left atrial (LA) enlargement, between methods., Methods: We prospectively measured LAV in 51 healthy volunteers using the four methods, and defined thresholds for moderate (mean+2 standard deviations [SDs]) and severe (mean+4 SDs) LA enlargement for each method. In 372 patients referred for echocardiography, we compared absolute LAV measurements and agreement between methods., Results: LAV was significantly different between methods in the healthy volunteer group (11 ± 4, 17 ± 3, 26 ± 6 and 28 ± 7 mL/m(2), respectively; P<0.0001), resulting in different thresholds for moderate and severe LA enlargement. LAV was also significantly different in the 372 patients (30 ± 20, 47 ± 27, 61 ± 34 and 65 ± 36 mL/m(2), respectively; P<0.0001). Agreement regarding degree of LA enlargement (none, moderate, severe), using the area-length method as reference, was modest with the cube method (kappa=0.41), correct with the ellipsoid method (kappa=0.60) and excellent with Simpson's method (kappa=0.83)., Conclusion: The choice of the method had a major effect on assessment of degree of LA enlargement. Our results suggest that the cube and ellipsoid methods, which significantly underestimated LAV and provided modest agreement, should be disregarded. In contrast, Simpson's method and the area-length method were slightly different, but showed close agreement, and should be preferred, using dedicated thresholds (50 and 56 mL/m(2) respectively)., (Copyright © 2015 Elsevier Masson SAS. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
15. Anatomical features of rheumatic and non-rheumatic mitral stenosis: potential additional value of three-dimensional echocardiography.
- Author
-
Krapf L, Dreyfus J, Cueff C, Lepage L, Brochet E, Vahanian A, and Messika-Zeitoun D
- Subjects
- Humans, Mitral Valve Stenosis congenital, Predictive Value of Tests, Prognosis, Risk Factors, Echocardiography, Three-Dimensional, Echocardiography, Transesophageal, Mitral Valve diagnostic imaging, Mitral Valve Stenosis diagnostic imaging, Radiation Injuries diagnostic imaging, Rheumatic Heart Disease diagnostic imaging
- Abstract
Although mitral stenosis is mostly due to rheumatic fever, other etiologies, such as degenerative, congenital, drug- or radiotherapy-induced mitral stenosis, are emerging and need to be recognized in order to decide the best therapeutic options. This pictorial review describes the echocardiographic features of these different anatomical types and the additional value of three-dimensional echocardiography., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
16. Iatrogenic aortic valve perforation assessed using three-dimensional transoesophageal echocardiography.
- Author
-
Dreyfus J, Feldman LJ, Lepage L, Brochet E, Berjeb N, Iung B, Vahanian A, and Messika-Zeitoun D
- Subjects
- Aortic Valve diagnostic imaging, Aortic Valve injuries, Aortic Valve Insufficiency etiology, Heart Injuries etiology, Humans, Male, Middle Aged, Predictive Value of Tests, Aortic Valve Insufficiency diagnostic imaging, Echocardiography, Doppler, Color, Echocardiography, Transesophageal, Heart Injuries diagnostic imaging, Iatrogenic Disease, Mitral Valve Annuloplasty adverse effects
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.